"Ozempic face" is a colloquial term describing the gaunt or hollowed appearance that some individuals experience after significant weight loss, particularly when using GLP-1 medications like Ozempic
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients
R., Plukker, J
Compounded medication disclosures: Omzo's footer, Terms, and site disclosures are among the most thorough in the category: explicitly stating that compounded medications are not FDA-approved, that the FDA hasn't reviewed them for safety/effectiveness/quality, that Omzo isn't a pharmacy, that products won't bear the Omzo name, and that individual results are not guaranteed
Current research provides some reassurance that GLP-1 agonists are not inherently dangerous for those with IBS, and in fact may offer additional gut benefits like reduced pain and improved barrier function
Summary ColonBroom GLP-1 Booster earns a 4.2 out of 5